Fosinopril inhibits protein and mRNA expression of thrombospondin-1 in cardiocytes with experimental diabetic rats

Hai-rong WANG,De-liang CHEN,Wei HU,Jian-lei CAO,Sheng-ping CHAO,Xue-dong GAN,Lin ZHANG,Shi-xi XIONG
DOI: https://doi.org/10.3760/cma.j.issn.1674-5809.2011.05.013
2011-01-01
Abstract:Objective To study the effect of fosinopril on the expression of thrombospondin-1 of cardiomyocytes in experimental diabetic rats.Methods A total of 30 SD rats models with diabetes were established by intraperitoneal injection of STZ,and then divided into:diabetes group and fosinopril treatment group.Another 8 healthy rats were set as control group.Collagen type Ⅰ,collagen type Ⅲ,transforming growth factor-β1 (TGF-31),angiotensin Ⅱ,tumor growth factor-β1 (TGF-β1) and thrombospondin-1 protein expression were determined by ABC immunohistochemical staining respectively,and the expression of TSP-1mRNA was determined via RT-PCR.Also we evaluated the expression of TSP-1 in mierovascular walls in cardiac.Results Compared with the control group,the expression of collagen type Ⅰ (0.36 ± 0.02 vs0.17 ±0.02,P <0.05),collagen type Ⅲ(0.35 ±0.03 vs0.15 ±0.02,P<0.05),TGF-β1 (0.39 ±0.04vs 0.17 ± 0.02,P < 0.05 ),and levels of Ang Ⅱ ( 11.33 ± 0.97 vs 6.11 ± 0.48,P < 0.05 ) were increased significantly in cardiac interstitial.In addition,TSP-1 was increased significantly in diabetic group when compared to the control group,and fosinopril suppressed these effects( TGF-β1 0.24 ± 0.07 vs 0.49 ±0.05,P < 0.05 ).But there was no significant difference in expression of TSP-1 in microvascular walls among these groups.The numbers of microvascular walls were decreased in diabetic group,but fosinopril increased the number.TSP-1 mRNA were highly expressed in the diabetic group compare with the control group( 2.01 ±0.41 vs 0.95 ±0.01,P<0.05),but fosinopril treatment decreased this high expression ( 1.02 ±0.01 vs2.25 ± 0.21,P < 0.05).Conclusion Compared with the control group,fosinopril inhibited the expression of Collagen type Ⅰ,Collagen type Ⅲ,TGF-β1 and TSP-1.Fosinopril decreased the cardiac fibrosis through lowering the levels of Ang Ⅱ and TSP-1,which may suppressed the activity of transformation-β1 and increased the metabolism of cardiomyocytes.
What problem does this paper attempt to address?